-- Days : -- HRS : -- MIN : -- SEC

Register Now →

Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

James F. Lancaster, PhD

Articles by James F. Lancaster, PhD

Safety and Clinical Efficacy of Zileuton in Patients with Chronic Asthma

ByStephen C. Lazarus, MD,Theodore Lee, MD,James P. Kemp, MD,Sally Wenzel, MD,Louise M. Dube, PhD,Rachel F. Ochs, MD, JD,Pierre J. Carpentier, MD,James F. Lancaster, PhD,the Zileuton Study Group

June 1st 1998

Randomized Trial of Zileuton in Patients with Moderate Asthma: Effect of Reduced Dosing Frequency and Amounts on Pulmonary Function and Asthma Symptoms

ByLawrence M. DuBuske, MD,Jay Grossman, MD,Louise M. Dube, PhD,Linda J. Swanson, PhD,James F. Lancaster, PhD,the Zileuton Study Group

April 1st 1997

Latest Updated Articles

Trending on AJMC

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

ATTR-CM Incidence, Prevalence Rose Sharply in the US

FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance

First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention

Zanubrutinib Tops Rivals in Real-World CLL Survival Study